Published in BMC Public Health on March 17, 2015
Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health (1997) 18.78
The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med (1993) 16.94
Socioeconomic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health. Lancet (1997) 11.25
Mortality decline and widening social inequalities. Lancet (1986) 10.56
Social class inequality in mortality from 1921 to 1972 in England and Wales. Popul Stud (Camb) (1985) 7.75
Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: the Renfrew and Paisley Study. J Epidemiol Community Health (1998) 6.99
Neighborhoods and health. Ann N Y Acad Sci (2010) 6.73
The size of mortality differences associated with educational level in nine industrialized countries. Am J Public Health (1994) 6.69
National trends in educational differentials in mortality. Am J Epidemiol (1989) 6.57
Income inequality, social cohesion and the health status of populations: the role of neo-liberalism. Soc Sci Med (2000) 6.54
Income inequality and population health: a review and explanation of the evidence. Soc Sci Med (2005) 6.17
Neighborhood social environment and risk of death: multilevel evidence from the Alameda County Study. Am J Epidemiol (1999) 4.99
The relationship between socioeconomic status and health: a review of the literature. Milbank Q (1993) 4.68
Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol (2005) 4.07
Adolescence and the social determinants of health. Lancet (2012) 3.56
Social inequalities in health: next questions and converging evidence. Soc Sci Med (1997) 3.55
Phantom of the area: poverty-area residence and mortality in the United States. Am J Public Health (1998) 3.36
Does the variation in the socioeconomic characteristics of an area affect mortality? BMJ (1996) 3.22
The Index of Multiple Deprivation 2000 and accessibility effects on health. J Epidemiol Community Health (2004) 2.92
All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. Am J Epidemiol (2002) 2.64
Breast, lung and colorectal cancer incidence and survival in South Thames Region, 1987-1992: the effect of social deprivation. J Public Health Med (1997) 2.56
Socioeconomic status and cancer survival in Ontario. J Clin Oncol (1997) 2.32
Neighbourhood deprivation and health: does it affect us all equally? Int J Epidemiol (2003) 2.29
Mortality and educational level among diabetic and non-diabetic population in the Turin Longitudinal Study: a 9-year follow-up. Int J Epidemiol (2004) 2.26
Socioeconomic status and risk of diabetes-related mortality in the U.S. Public Health Rep (2010) 2.21
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ (2008) 2.10
Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Med (2012) 2.07
Individual- and area-level socioeconomic status variables as predictors of mortality in a cohort of 179,383 persons. Am J Epidemiol (2004) 1.92
Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer (2010) 1.77
The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer (2010) 1.58
Socioeconomic status and ischaemic heart disease mortality in 10 western European populations during the 1990s. Heart (2005) 1.48
Socioeconomic context in area of living and risk of myocardial infarction: results from Stockholm Heart Epidemiology Program (SHEEP). J Epidemiol Community Health (2002) 1.31
Social position and mortality from respiratory diseases in males and females. Eur Respir J (2003) 1.26
Socioeconomic status, structural and functional measures of social support, and mortality: The British Whitehall II Cohort Study, 1985-2009. Am J Epidemiol (2012) 1.21
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials. Trials (2011) 1.17
Do patient characteristics, disease, or treatment explain social inequality in survival from colorectal cancer? Soc Sci Med (2009) 1.17
Socioeconomic status and ischaemic heart disease mortality in middle-aged men: importance of the duration of follow-up. The Copenhagen Male Study. Int J Epidemiol (2001) 0.98
Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention. Circ Cardiovasc Interv (2012) 0.96
Cancer surpasses heart disease as leading cause of death for all but the very elderly. J Natl Cancer Inst (2005) 0.95
The association between deprivation and hospital mortality for admissions to critical care units in England. J Crit Care (2010) 0.94
Increasing mortality differentials by residential area level of poverty: Britain 1981-1997. Soc Sci Med (2000) 0.90
Trends in educational inequalities in mortality, seven types of cancers, Norway 1971-2002. Eur J Public Health (2011) 0.82
Variations in life expectancy between rural and urban areas of England, 2001-07. Health Stat Q (2010) 0.80
Six employment conditions and health inequalities: a descriptive overview. Int J Health Serv (2010) 0.80
Social inequalities in female mortality by region and by selected causes of death, England and Wales, 2001-03. Health Stat Q (2009) 0.79
Health in austerity: hard decisions for hard times. Lancet (2014) 0.76
Epigenetic stem cell signature in cancer. Nat Genet (2006) 9.62
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res (2010) 6.03
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res (2007) 3.79
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One (2009) 3.33
A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med (2006) 3.09
Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol (2010) 2.71
Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol (2003) 2.58
Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health (2006) 2.54
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation (2010) 2.31
Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics (2004) 2.15
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ (2008) 2.10
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. Gynecol Oncol (2011) 2.04
Cancer survivors information seeking behaviors: a comparison of survivors who do and do not seek information about cancer. Patient Educ Couns (2006) 1.94
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92
Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. J Clin Oncol (2012) 1.90
Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option. Clin Cancer Res (2004) 1.87
Macroscopically detected female genital injury after consensual and non-consensual vaginal penetration: a prospective comparison study. J Forensic Leg Med (2013) 1.86
An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Hum Mol Genet (2003) 1.85
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study. Lancet Oncol (2013) 1.83
Part 5: Adult basic life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation (2010) 1.80
Ovarian cancer symptom awareness and anticipated time to help-seeking for symptoms among UK women. J Fam Plann Reprod Health Care (2013) 1.79
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One (2008) 1.75
Socioeconomic inequalities in oral health in different European welfare state regimes. J Epidemiol Community Health (2013) 1.74
Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. Clin Chem (2007) 1.73
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res (2011) 1.64
Comparison of tailored interventions to increase mammography screening in nonadherent older women. Prev Med (2003) 1.64
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol (2010) 1.60
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59
Socioeconomic inequalities in all-cause mortality in the Czech Republic, Russia, Poland and Lithuania in the 2000s: findings from the HAPIEE Study. J Epidemiol Community Health (2013) 1.58
Hypothermia is a significant medical risk of mass participation long-distance open water swimming. Wilderness Environ Med (2009) 1.51
Job insecurity and health: a study of 16 European countries. Soc Sci Med (2010) 1.50
SCORE performance in Central and Eastern Europe and former Soviet Union: MONICA and HAPIEE results. Eur Heart J (2013) 1.50
Screening for familial ovarian cancer: the need for well-designed prospective studies. J Clin Oncol (2005) 1.48
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47
Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study. Menopause (2015) 1.46
A breast cancer fear scale: psychometric development. J Health Psychol (2004) 1.45
Methodological development of an exploratory randomised controlled trial of an early years' nutrition intervention: the CHERRY programme (Choosing Healthy Eating when Really Young). Matern Child Nutr (2013) 1.44
Improving cancer outcomes through international collaboration in academic cancer treatment trials. J Clin Oncol (2009) 1.43
Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation (2010) 1.43
Validation of a modified table to map the 1998 Abbreviated Injury Scale to the 2008 scale and the use of adjusted severities. J Trauma (2011) 1.42
Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet (2009) 1.42
Development of a self-efficacy scale for mammography. Res Nurs Health (2005) 1.40
Life span and disability: a cross sectional comparison of Russian and Swedish community based data. BMJ (2004) 1.39
Therapeutic hypothermia for birth asphyxia in low-resource settings: a pilot randomised controlled trial. Lancet (2008) 1.37
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Health behaviors in cancer survivors. Oncol Nurs Forum (2007) 1.33
Neighbourhood socioeconomic status and cardiovascular risk factors: a multilevel analysis of nine cities in the Czech Republic and Germany. BMC Public Health (2007) 1.32
Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression. Int J Oncol (2004) 1.31
A cost-effectiveness comparison of three tailored interventions to increase mammography screening. J Womens Health (Larchmt) (2004) 1.31
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiol Biomarkers Prev (2013) 1.22